Risk Communication Within Mexican-American Families
This study will examine what methods work best for encouraging Mexican-American family members to talk about their risk for diabetes, heart disease, breast cancer and colon cancer. Within the Mexican-American community, the family culture provides an important setting in which individuals interpret and share their health information and formulate strategies to engage in health-promoting behaviors. The information from the study will be used to design risk communication approaches for Mexican-American households.
Members of households with at least three adults 18 to 70 years of age who are part of the existing Mexican-American households recruited by the University of Texas M.D. Anderson Cancer Center may be eligible for this study.
Participants are interviewed about their medical history, family history of disease, health behaviors, beliefs about disease and disease risk, experiences living in the United States, and relationships with family members and close friends. They are then provided information about their family risk for diabetes, heart disease, breast cancer and colon cancer, based on the information they provided in the interview. Two additional interviews are conducted over the telephone that include questions about how the participants communicate with family members about their risk and health behaviors.
|Diabetes Colon Cancer Cardiovascular Disease||Behavioral: Family Health History|
|Study Design:||Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: No masking
Primary Purpose: Prevention
|Official Title:||The Role of Family History and Culture in Communal Coping Within Mexican-American Families|
- Family Communication about Risk
- Illness representations, Cooperative strategies to screen and adopt healthy behaviors
|Study Start Date:||April 27, 2007|
|Study Completion Date:||December 13, 2010|
|Primary Completion Date:||December 13, 2010 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00469339
|United States, Maryland|
|National Human Genome Research Institute (NHGRI), 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|
|Principal Investigator:||Laura M. Koehly, Ph.D.||National Human Genome Research Institute (NHGRI)|